Drug intelligence / Profile preview

Liv-Herbal Formula

Development stage: Preclinical
Lead developer: BIOHERB
Administration: Oral

Overview

Liv-Herbal Formula is a natural herbal medicine developed by Bio-Herb Remedies Inc. (BIOHERB) for the treatment of various liver diseases, including Hepatitis B, Hepatitis C, liver cirrhosis, and fatty liver disease. Formulated by Dr. Syed Toora and Dr. Rashbinder Hashimi, the product is a blend of natural herbal extracts designed to reverse liver damage, improve liver enzyme levels, and reduce liver fibrosis. According to company reports, the formula has demonstrated the ability to reduce viral loads by up to 99% in hepatitis patients. While the company cites over 15 years of clinical data and case reports, the product has not yet received formal clinical phase designations or regulatory approval as a pharmaceutical drug, and its specific molecular targets remain undisclosed.

Brand names: Liv-Herbal Formula

Beyond the preview

Go deeper on Liv-Herbal Formula.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Liv-Herbal Formula.

Explore the full profile